Collagen type XIV is proportionally lower in the lung tissue of patients with IPF.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 11 2023
Historique:
received: 27 07 2023
accepted: 04 11 2023
medline: 9 11 2023
pubmed: 8 11 2023
entrez: 8 11 2023
Statut: epublish

Résumé

Abnormal deposition of extracellular matrix (ECM) in lung tissue is a characteristic of idiopathic pulmonary fibrosis (IPF). Increased collagen deposition is also accompanied by altered collagen organization. Collagen type XIV, a fibril-associated collagen, supports collagen fibril organization. Its status in IPF has not been described at the protein level yet. In this study, we utilized publicly available datasets for single-cell RNA-sequencing for characterizing collagen type XIV expression at the gene level. For protein level comparison, we applied immunohistochemical staining for collagen type XIV on lung tissue sections from IPF patients and compared it to lung tissue sections from never smoking and ex-smoking donors. Analyzing the relative amounts of collagen type XIV at the whole tissue level, as well as in parenchyma, airway wall and bronchial epithelium, we found consistently lower proportions of collagen type XIV in all lung tissue compartments across IPF samples. Our study suggests proportionally lower collagen type XIV in IPF lung tissues may have implications for the assembly of the ECM fibers potentially contributing to progression of fibrosis.

Identifiants

pubmed: 37938243
doi: 10.1038/s41598-023-46733-5
pii: 10.1038/s41598-023-46733-5
pmc: PMC10632429
doi:

Substances chimiques

Fibril-Associated Collagens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19393

Informations de copyright

© 2023. The Author(s).

Références

J Clin Invest. 2014 Apr;124(4):1622-35
pubmed: 24590289
J Mol Cell Cardiol. 2012 Nov;53(5):626-38
pubmed: 22906538
Dev Dyn. 1996 May;206(1):49-58
pubmed: 9019246
Nat Rev Dis Primers. 2017 Oct 20;3:17074
pubmed: 29052582
J Biol Chem. 2005 Nov 18;280(46):38537-43
pubmed: 16129687
Cell. 2016 Apr 21;165(3):535-50
pubmed: 27104977
Sci Adv. 2020 Jul 08;6(28):eaba1983
pubmed: 32832599
Eur Respir J. 2017 Jul 5;50(1):
pubmed: 28679607
J Histochem Cytochem. 2006 Jun;54(6):693-700
pubmed: 16461366
Dis Model Mech. 2017 Nov 1;10(11):1301-1312
pubmed: 29125826
Am J Pathol. 2021 Dec;191(12):2184-2194
pubmed: 34560063
J Clin Invest. 2018 Jan 2;128(1):45-53
pubmed: 29293088
Am J Physiol Lung Cell Mol Physiol. 2023 Jun 1;324(6):L799-L814
pubmed: 37039368
Nat Med. 2023 Jun;29(6):1563-1577
pubmed: 37291214
Nat Rev Genet. 2012 Mar 13;13(4):227-32
pubmed: 22411467
Mol Syst Biol. 2016 Oct 20;12(10):883
pubmed: 27951527
Biomaterials. 2023 Feb;293:121960
pubmed: 36580718
Am J Respir Crit Care Med. 2012 Nov 1;186(9):866-76
pubmed: 22936357
J Biol Chem. 1994 Nov 11;269(45):28193-9
pubmed: 7961756
Matrix Biol. 2004 Jan;22(7):595-601
pubmed: 15065570
J Biol Chem. 2009 Mar 27;284(13):8427-38
pubmed: 19136672
Anat Rec A Discov Mol Cell Evol Biol. 2003 Dec;275(2):1073-80
pubmed: 14613307

Auteurs

Mehmet Nizamoglu (M)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 [HPC EA11], 9713 GZ, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Maunick Lefin Koloko Ngassie (ML)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 [HPC EA11], 9713 GZ, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Rhode A Meuleman (RA)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 [HPC EA11], 9713 GZ, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Martin Banchero (M)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 [HPC EA11], 9713 GZ, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Theo Borghuis (T)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 [HPC EA11], 9713 GZ, Groningen, The Netherlands.

Wim Timens (W)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 [HPC EA11], 9713 GZ, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Martijn C Nawijn (MC)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 [HPC EA11], 9713 GZ, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Barbro N Melgert (BN)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 [HPC EA11], 9713 GZ, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Department of Molecular Pharmacology, Groningen Research Institute for Pharmacy, University of Groningen, Groningen, The Netherlands.

Irene H Heijink (IH)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 [HPC EA11], 9713 GZ, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Department of Pulmonology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Corry-Anke Brandsma (CA)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 [HPC EA11], 9713 GZ, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Janette K Burgess (JK)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 [HPC EA11], 9713 GZ, Groningen, The Netherlands. j.k.burgess@umcg.nl.
Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. j.k.burgess@umcg.nl.
W.J. Kolff Institute for Biomedical Engineering and Materials Science-FB41, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. j.k.burgess@umcg.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH